Neuroendocrine Control of Growth Hormone Secretion
Department of Pharmacology, Chemotherapy, and Toxicology, University of Milan, Milan; and Department of Biomedical and Biotechnology Sciences, University of Brescia, Brescia, Italy Müller, Eugenio E., Vittorio Locatelli, and Daniela Cocchi. The secretion of growth hormone (GH) is regulated through a...
Saved in:
Published in | Physiological reviews Vol. 79; no. 2; pp. 511 - 607 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Am Physiological Soc
01.04.1999
American Physiological Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Department of Pharmacology, Chemotherapy, and Toxicology,
University of Milan, Milan; and Department of Biomedical and
Biotechnology Sciences, University of Brescia, Brescia,
Italy
Müller, Eugenio E.,
Vittorio Locatelli, and
Daniela Cocchi.
The secretion of growth
hormone (GH) is regulated through a complex neuroendocrine control
system, especially by the functional interplay of two hypothalamic
hypophysiotropic hormones, GH-releasing hormone (GHRH) and
somatostatin (SS), exerting stimulatory and inhibitory influences,
respectively, on the somatotrope. The two hypothalamic neurohormones
are subject to modulation by a host of neurotransmitters, especially
the noradrenergic and cholinergic ones and other hypothalamic
neuropeptides, and are the final mediators of metabolic, endocrine,
neural, and immune influences for the secretion of GH. Since the
identification of the GHRH peptide, recombinant DNA procedures have
been used to characterize the corresponding cDNA and to clone GHRH
receptor isoforms in rodent and human pituitaries. Parallel to research
into the effects of SS and its analogs on endocrine and exocrine
secretions, investigations into their mechanism of action have led to
the discovery of five separate SS receptor genes encoding a family of G
protein-coupled SS receptors, which are widely expressed in the
pituitary, brain, and the periphery, and to the synthesis of analogs
with subtype specificity. Better understanding of the function of GHRH,
SS, and their receptors and, hence, of neural regulation of GH
secretion in health and disease has been achieved with the discovery of a new class of fairly specific, orally active, small peptides and their
congeners, the GH-releasing peptides, acting on specific, ubiquitous seven-transmembrane domain receptors, whose natural ligands are not yet known. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ISSN: | 0031-9333 1522-1210 |
DOI: | 10.1152/physrev.1999.79.2.511 |